作为新型向抗癌疗法的标,PSF-lncRNA相互作用
Ren Liu1, Xiaojing Wang1, Min Zhou1
1School of Pharmacy and Pharmaceutical Sciences & Institute of Materia Medica, Shandong First Medical University & Shandong Academy of Medical Sciences, NHC Key Laboratory of Biotechnology Drugs (Shandong Academy of Medical Sciences), Key Lab for Rare & Uncommon Diseases of Shandong Province, Jinan, Shandong 250117, China.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
|September 27, 2024
概括
聚皮里米丁管结合蛋白相关分离因子 (PSF) 通过表观遗传调节和替代分离驱动癌症的进展. 准PSF-lncRNA相互作用为侵袭性癌症提供了一个有前途的治疗策略,包括多种质母细胞瘤.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 聚皮里米丁管结合蛋白关联分离因子 (PSF),是多索菲拉行为/人类分离 (DBHS) 复合物的组成部分,与癌症发病有关.
- 在表观遗传调节,长非编码RNA (lncRNA) 相互作用和替代拼接中PSF的作用有助于癌细胞的增殖,迁移,入侵,转移和耐药性.
研究的目的:
- 综合目前对PSF在致癌途径中的作用的理解.
- 审查最近在识别PSF-lncRNA相互作用的抑制剂方面的进展.
- 讨论这些抑制剂在癌症治疗中的潜力,特别是与免疫检查点阻塞疗法结合用于多形质母细胞瘤 (GBM).
主要方法:
- 文献综述和综合现有关于PSF, lncRNAs和癌症的研究.
- 对PSF在各种癌症特征中的参与进行分析.
- 检查针对PSF-lncRNA相互作用的治疗策略.
主要成果:
- 通过表观遗传和拼接机制,PSF是癌症进展的关键调解者.
- 准PSF-lncRNA相互作用为侵袭性癌症提供了一个可行的治疗途径.
- 在GBM中,PSF抑制剂可能会增强抗PD-(L) 1疗法的疗效.
结论:
- 由于其在瘤发生过程中的多方面的作用,PSF是癌症治疗的关键目标.
- 开发特定的PSF-lncRNA相互作用抑制剂对于推进癌症治疗至关重要.
- 涉及PSF抑制剂和免疫检查点阻塞的组合疗法显示出改善GBM结果的潜力.
更多相关视频
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:39lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:26Protein Networks
3.9K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
3.9K